Unfortunately, if we limit the use of these viral vector vaccines to specific ages it will slow public vaccination. The EMA advised: “Benefits continue to far outweigh the risks.” Internationally, the situation is precarious with 1.9m Covid cases in India over seven days. With Covid and vector vaccines it has been misapplied, incorrectly limiting assessments to national rather than a global outlook. Risks with viral vector vaccines are low; patients who suffer reactions can be treated. What is uncertain, and where we should apply the precautionary principle, is how Covid variants will spread; we cannot afford to turn our noses up at safe and effective vaccines.

Source: Irish Examiner April 26, 2021 08:16 UTC